High Net Worth Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.28M Buy
15,683
+102
+0.7% +$14.1K 0.48% 50
2026
Q2
$2M Buy
15,581
+366
+2% +$42.8K 0.42% 57
2026
Q1
$1.83M Buy
15,215
+119
+0.8% +$13.7K 0.43% 59
2025
Q4
$1.59M Sell
15,096
-812
-5% -$76.2K 0.37% 65
2025
Q3
$1.34M Sell
15,908
-1,513
-9% -$125K 0.32% 71
2025
Q2
$1.38M Sell
17,421
-2,319
-12% -$184K 0.37% 62
2025
Q1
$1.77M Buy
19,740
+3,281
+20% +$306K 0.5% 51
2024
Q4
$1.64M Buy
16,459
+250
+2% +$25.8K 0.46% 54
2024
Q3
$1.84M Sell
16,209
-33
-0.2% -$3.92K 0.5% 50
2024
Q2
$2.01M Sell
16,242
-116
-0.7% -$14.9K 0.61% 42
2024
Q1
$2.16M Buy
16,358
+25
+0.2% +$3.08K 0.68% 37
2023
Q4
$1.78M Sell
16,333
-104
-0.6% -$10.8K 0.66% 38
2023
Q3
$1.69M Buy
16,437
+71
+0.4% +$7.65K 0.68% 39
2023
Q2
$1.89M Buy
16,366
+848
+5% +$96.3K 0.73% 36
2023
Q1
$1.65M Sell
15,518
-509
-3% -$55K 0.67% 40
2022
Q4
$1.78M Sell
16,027
-1,244
-7% -$127K 0.69% 35
2022
Q3
$1.49M Sell
17,271
-100
-0.6% -$8.93K 0.64% 42
2022
Q2
$1.58M Buy
17,371
+3,313
+24% +$294K 0.66% 42
2022
Q1
$1.15M Buy
14,058
+637
+5% +$50.2K 0.42% 57
2021
Q4
$1.03M Buy
+13,421
New +$1.07M 0.36% 62

Other funds holding MRK

High Net Worth Advisory Group's MRK Position: Q3 2026 in Review

High Net Worth Advisory Group increased its Merck (MRK) stake by 0.65% in Q3 2026, buying an estimated $14.1K and bringing the position to 15,683 shares worth $2.28M. The position accounts for 0.48% of the portfolio, ranked #50.

High Net Worth Advisory Group first reported a position in MRK in Q4 2021 and has held it in 20 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • High Net Worth Advisory Group held 15,683 shares of Merck worth $2.28M as of Q3 2026.
  • High Net Worth Advisory Group bought 102 Merck shares in Q3 2026, an estimated $14.1K.
  • Merck made up 0.48% of High Net Worth Advisory Group's portfolio in Q3 2026, its #50 holding.
  • High Net Worth Advisory Group first reported a position in Merck in Q4 2021 and has held it in 20 quarters since.
  • 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on High Net Worth Advisory Group's 13F filing for Q3 2026, filed 26 Oct 2026.